Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte d'Ivoire

No abstract is available for this paper.

• Publication year

  2003

• Venue

  AIDS (London)

• Publication date

  2003-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00002030-200317003-00002PMID 14565604
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Overcoming challenges to the implementation of antiretroviral therapy in Kenya.

  2002cited by this paper
• Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance.

  2002cited by this paper
• Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial.

  2001cited by this paper
• Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults

  2001cited by this paper
• Community-based approaches to HIV treatment in resource-poor settings.

  2001cited by this paper
• HIV/AIDS Treatment for Millions

  2001cited by this paper
• Public health. HIV/AIDS treatment for millions.

  2001cited by this paper
• Genetic Analysis of Human Immunodeficiency Virus in Abidjan, Ivory Coast Reveals Predominance of HIV Type 1 Subtype A and Introduction of Subtype G

  1999cited by this paper
• Evaluation of HIV serial and parallel serologic testing algorithms in Abidjan, Côte d'Ivoire.

  1999cited by this paper
• Natural history of HIV infection in the era of combination antiretroviral therapy.

  1999cited by this paper
• Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

  1998cited by this paper
• Antiretrovirals for developing world.

  1998cited by this paper
• Field Evaluation of a Combination of Monospecific Enzyme-Linked Immunosorbent Assays for Type-Specific Diagnosis of Human Immunodeficiency Virus Type 1 (HIV-1) and HIV-2 Infections in HIV-Seropositive Persons in Abidjan, Ivory Coast

  1998cited by this paper
• Comparison of NucliSens and Amplicor Monitor Assays for Quantification of Human Immunodeficiency Virus Type 1 (HIV-1) RNA in Plasma of Persons with HIV-1 Subtype A Infection in Abidjan, Côte d’Ivoire

  1998cited by this paper
• Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection.

  1998cited by this paper
• Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

  1998cited by this paper
• A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.

  1998cited by this paper
• The challenge of providing effective care for HIV/AIDS in Africa.

  1997cited by this paper
• Antiretroviral treatment in Africa.

  1997cited by this paper
• 4. Modelling Survival Data in Medical Research

  1995cited by this paper
• Maximum likelihood for interval censored data: Consistency and computation

  1994cited by this paper
• 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.

  1993cited by this paper
• Longitudinal data analysis using generalized linear models

  1986cited by this paper
• A VARIABLE SPAN SMOOTHER

  1984cited by this paper

• Leveraging data science and machine learning for urban climate adaptation in two major African cities: a HE2AT Center study protocol

  2024cites this paper
• Predictors of mortality rate among adult HIV-positive patients on antiretroviral therapy in Metema Hospital, Northwest Ethiopia: a retrospective follow-up study

  2021cites this paper
• Long-term immunological responses to treatment among HIV-2 patients in Côte d’Ivoire

  2020cites this paper
• Use of pre‐ART laboratory screening to identify renal, hepatic and haematological abnormalities in Côte d'Ivoire

  2020cites this paper
• [Survival in HIV-1 patients receiving antiretroviral therapy in Morocco].

  2018cites this paper
• Health care provider communication training in rural Tanzania empowers HIV‐infected patients on antiretroviral therapy to discuss adherence problems

  2017cites this paper
• Predictors of Survival among Adult Ethiopian Patients in the National ART Program at Seven University Teaching Hospitals: A Prospective Cohort Study

  2017cites this paper
• A Comparison of Effectiveness of Efavirenz and Nevirapine - Based First-Line HIV Treatment in Patients Attending Coast Provincial General Hospital, Mombasa County, Kenya

  2017cites this paper
• Screening for cervical carcinoma in HIV‐infected women: Analysis of main risk factors for cervical cytologic abnormalities

  2017cites this paper
• Quantification of HIV-1 Proviral DNA Forms in Gut Tissues Using Real-Time PCR

  2015cites this paper
• Causes of Death in Hospitalized HIV Patients in the Early Anti-Retroviral Therapy Era.

  2015cites this paper
• Hepatitis B and HIV co-infection is still treated using lamivudine-only antiretroviral therapy combination in Uganda.

  2015cites this paper
• Outcomes of antiretroviral treatment in HIV-infected adults: a dynamic and observational cohort study in Shenzhen, China, 2003–2014

  2015cites this paper
• 10 – Clinical Features and Management of HIV/AIDS

  2014cites this paper
• Survival and predictors of mortality among adult patients on highly active antiretroviral therapy at Debre-Markos Referral Hospital, north west Ethiopia; a retrospective cohort study.

  2014cites this paper
• Which strategy for ART in resource-limited settings?

  2014cites this paper
• Prise en charge des personnes vivant avec le virus de l'immunodéficience humaine en zone décentralisée au Cameroun

  2014cites this paper
• Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria

  2013cites this paper
• Viral suppression after 12 months of antiretroviral therapy in low- and middle-income countries: a systematic review.

  2013cites this paper
• The use of haemoglobin and body mass index as predictors of mortality in HIV patients newly initiated on highly active antiretroviral therapy

  2013cites this paper
• A novel pharmacokinetic approach to predict virologic failure in HIV-1-infected paediatric patients

  2013cites this paper
• Impact of definitions of loss to follow-up on estimates of retention, disease progression, and mortality: application to an HIV program in Mozambique.

  2013cites this paper
• Factors associated with virological failure in a cohort of combination antiretroviral therapy-treated patients managed at a tertiary referral centre.

  2013cites this paper
• Performance evaluation of the MBio Diagnostics point-of-care CD4 counter.

  2013cites this paper
• Key social and behavioural factors influencing clinical outcomes for people with HIV receiving antiretroviral therapy in diverse settings

  2013cites this paper
• Intérêt du traitement antirétroviral précoce chez l’adulte infecté par le VIH en Afrique sub-Saharienne

  2012cites this paper
• CD4, Viral Load Response, and Adherence Among Antiretroviral-Naive Breast-feeding Women Receiving Triple Antiretroviral Prophylaxis for Prevention of Mother-to-Child Transmission of HIV in Kisumu, Kenya

  2012cites this paper
• Accessibility of antiretroviral therapy in Ghana: Convenience of access

  2012cites this paper
• Monitoring of Early Field Hepatic Tolerance to NNRTI-Based Regimens with Multiple Biochemical Parameters in Ivorian HIV-1-Infected Patients: A Pilot Study

  2012cites this paper
• Excellent Clinical Outcomes and High Retention in Care Among Adults in a Community-Based HIV Treatment Program in Rural Rwanda

  2012cites this paper
• Short Term Survival after Anti-Retroviral Therapy Initiation among Aids Patients from South India

  2011cites this paper
• Four-Year Treatment Outcomes of Adult Patients Enrolled in Mozambique's Rapidly Expanding Antiretroviral Therapy Program

  2011cites this paper
• Predicting adherence to antiretroviral therapy and retention to HIV care : effects of baseline biopsychosocial status and neuropsychological functioning

  2011influential citation
• Improved antiretroviral treatment outcome in a rural African setting is associated with cART initiation at higher CD4 cell counts and better general health condition

  2011cites this paper
• Long term virological, immunological and mortality outcomes in a cohort of HIV-infected female sex workers treated with highly active antiretroviral therapy in Africa

  2011cites this paper
• Retention in an antiretroviral therapy programme during an era of decreasing drug cost in Limbe, Cameroon

  2011cites this paper
• Making HIV programmes work: The Heineken workplace programme to prevent and treat HIV infection 2001- 2010

  2011cites this paper
• Association of Mortality and Immunological Response after Initiating Antiretroviral Therapy among HIV-infected Patients in Khon Kaen: A Cohort Study

  2011cites this paper
• Early Mortality in Adults Initiating Antiretroviral Therapy (ART) in Low- and Middle-Income Countries (LMIC): A Systematic Review and Meta-Analysis

  2011cites this paper
• Linking HIV Prevention and Care for Community Interventions Among High-Risk Women in Burkina Faso—The ARNS 1222 “Yerelon” Cohort

  2011cites this paper
• Early Mortality and AIDS Progression Despite High Initial Antiretroviral Therapy Adherence and Virologic Suppression in Botswana

  2011cites this paper
• Commentary: Scaling up HIV treatment in resource-limited countries: The challenge of staff shortages

  2011cites this paper
• Development and validation of a clinical score for prognosis stratification in patients requiring antiretroviral therapy in sub-Saharan Africa: a prospective open cohort study

  2011influential citation
• Program-level and contextual-level determinants of low-median CD4+ cell count in cohorts of persons initiating ART in eight sub-Saharan African countries

  2011cites this paper
• Adherence to highly active antiretroviral treatment and loss to follow-up of pregnent women at the Themba Lethu Clinicu

  2011cites this paper
• UvA-DARE ( Digital Academic Repository ) Making HIV programmes work : The Heineken workplace programme to prevent and treat HIV infection 2001-2010

  2011cites this paper
• Non-Nucleoside Reverse Transcriptase Inhibitor Outcomes Among cART-Treated Adults in Botswana

  2011cites this paper
• Is the Recommended Once-Daily Dose of Lamivudine Optimal in West African HIV-Infected Children?

  2010cites this paper
• The Effect of Community-Based Support Services on Clinical Efficacy and Health-Related Quality of Life in HIV/AIDS Patients in Resource-Limited Settings in Sub-Saharan Africa

  2010cites this paper
• Predictors of virologic failure in HIV-1-infected adults on first line antiretroviral therapy in eight provinces in China

  2010cites this paper
• Initiation of antiretroviral therapy among pregnant women in resource-limited countries: CD4+ cell count response and program retention

  2010cites this paper
• Access to antiretroviral treatment in developing countries: Which financing strategies are possible?

  2010cites this paper
• Treating HIV in rural South Africa “Successes and Challenges"

  2010cites this paper
• Non-nucleoside reverse transcriptase inhibitor outcomes among combination antiretroviral therapy-treated adults in Botswana

  2010cites this paper
• COHORT PROFILE Cohort Profile : Hlabisa HIV Treatment and Care Programme

  2010cites this paper
• Accès aux traitements antirétroviraux dans les pays en développement : quelles stratégies de financement ?

  2010cites this paper
• Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review.

  2010cites this paper
• AIDS Denialism and Public Health Practice

  2010cites this paper
• Predictors of virologic failure in HIV-1-infected adults receiving first-line antiretroviral therapy in 8 provinces in China.

  2010cites this paper
• Patients with Advanced HIV Type 1 Infection Initiating Antiretroviral Therapy in Botswana: Treatment Response and Mortality

  2009cites this paper
• Didanosine Population Pharmacokinetics in West African Human Immunodeficiency Virus-Infected Children Administered Once-Daily Tablets in Relation to Efficacy after One Year of Treatment

  2009cites this paper
• Quality of life, psychosocial health, and antiretroviral therapy among HIV-positive women in Zimbabwe

  2009cites this paper
• Morbidity in HIV-1-Infected children treated or not treated with highly active antiretroviral therapy (HAART), Abidjan, Cote d'Ivoire, 2000-04.

  2009cites this paper
• HIV Type 1 Drug Resistance in Adults Receiving Highly Active Antiretroviral Therapy in Abidjan, Côte d'Ivoire

  2009cites this paper
• Response to Zidovudine/Didanosine-Containing Combination Antiretroviral Therapy Among HIV-1 Subtype C-Infected Adults in Botswana: Two-Year Outcomes from a Randomized Clinical Trial

  2009influential citation
• ADDIS ABABA UNIVERSITY FACULTY OF MEDICINE SCHOOL OF PUBLIC HEALTH FIRST LINE ANTIRETROVIRAL TREATMENT FAILURE AND FACTORS ASSOCIATED WITH IT IN ADDIS

  2009cites this paper
• Mortality of HIV-Infected Patients Starting Antiretroviral Therapy in Sub-Saharan Africa: Comparison with HIV-Unrelated Mortality

  2009cites this paper
• COMMENTARY: understanding the benefits of pediatric anti-retroviral treatment in resource-limited settings.

  2009cites this paper
• Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far‐North Province, Cameroon

  2009cites this paper
• Loss to Follow-Up of Adults in Public HIV Care Systems in Central Mozambique: Identifying Obstacles to Treatment

  2009cites this paper
• Adult combination antiretroviral therapy in sub-Saharan Africa: lessons from Botswana and future challenges.

  2009cites this paper
• Mortality and morbidity among HIV type-1-infected patients during the first 5 years of a multicountry HIV workplace programme in Africa

  2009cites this paper
• The effeciveness and determinants of effectiveness of antiretroviral therapy for adults in the Western Cape Province, South Africa

  2009cites this paper
• Evaluating the impact of antiretroviral therapy on HIV transmission.

  2008cites this paper
• Antiretroviral therapy in resource‐limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub‐Saharan Africa, Asia and Latin America

  2008cites this paper
• Overestimates of Survival after HAART: Implications for Global Scale-Up Efforts

  2008cites this paper
• Low Prevalence of Detectable HIV Plasma Viremia in Patients Treated With Antiretroviral Therapy in Burkina Faso and Mali

  2008cites this paper
• Change over time of mortality predictors after HAART initiation in a Senegalese cohort

  2008cites this paper
• Determinants of retention in care in an antiretroviral therapy (ART) program in urban Cameroon, 2003–2005

  2008cites this paper
• Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa

  2008cites this paper
• Efficacy of Antiretroviral Therapy in Africa: Effect on Immunological and Virological Outcome Measures – A Meta-Analysis a

  2008cites this paper
• Efavirenz versus indinavir chez les patients naïfs infectés par le VIH-1 à Abidjan ( Côte d ’ Ivoire ) Efavirenz versus indinavir among HIV-1 naive patients in Abidjan ( Ivory Coast )

  2008influential citation
• Virologic and Immunologic Response to Antiretroviral Therapy and Predictors of HIV Type 1 Drug Resistance in Children Receiving Treatment in Abidjan, Côte d'Ivoire

  2008cites this paper
• Changes in Outcome of Persons Initiating Highly Active Antiretroviral Therapy at a CD4 Count Less Than 50 Cells/mm3

  2008cites this paper
• Long-Term Efficacy and Tolerance of Efavirenz- and Nevirapine-Containing Regimens in Adult HIV Type 1 Senegalese Patients

  2008cites this paper
• A study to explore the impact of socio-demographic factors on the response to antiretroviral therapy in Gauteng Department of Health

  2008cites this paper
• [Efavirenz versus indinavir among HIV-1 naive patients in Abidjan (Ivory Coast)].

  2008cites this paper
• Le traitement antirétroviral en Côte d'Ivoire : observance, surveillance immunologique et impact sur les comportements vis-à-vis du VIH/SIDA

  2008cites this paper
• Rapid scaling-up of antiretroviral therapy in 10 000 adults in Côte d'Ivoire: 2-year outcomes and determinants

  2008cites this paper
• Clinical Toxicity of Highly Active Antiretroviral Therapy in a Home-Based AIDS Care Program in Rural Uganda

  2007cites this paper
• The Evolving Cost of HIV in South Africa: Changes in Health Care Cost With Duration on Antiretroviral Therapy for Public Sector Patients

  2007cites this paper
• Predictors of Long-Term Viral Failure Among Ugandan Children and Adults Treated With Antiretroviral Therapy

  2007cites this paper
• A Program to Provide Antiretroviral Therapy to Residents of an Urban Slum in Nairobi, Kenya

  2007cites this paper
• Early antiretroviral therapy mortality in resource-limited settings: what can we do about it?

  2007cites this paper
• Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic Review

  2007cites this paper
• Longitudinal effect following initiation of highly active antiretroviral therapy on plasma and cervico-vaginal HIV-1 RNA among women in Burkina Faso

  2007cites this paper
• Establishing a workplace antiretroviral therapy programme in South Africa

  2007cites this paper
• Brief Report: Effectiveness of Combination Antiretroviral Therapy on Survival and Opportunistic Infections in a Developing World Setting: An Observational Cohort Study

  2007cites this paper
• HIV drug resistance surveillance for prioritizing treatment in resource-limited settings

  2007cites this paper
• Antiretroviral Durability and Tolerability in HIV-Infected Adults Living in Urban Kenya

  2007cites this paper